Healthcare -
Biotechnology - NASDAQ - US
$ 20.285
-1.96 %
$ 15 B
Market Cap
-65.44
P/E
SMMT - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative SMMT - Summit Therapeutics Inc.
28.2 M
LAST VALUE
9.32%
2 YEAR CAGR
11.75%
5 YEAR CAGR
24.17%
10 YEAR CAGR